HGP-3918

N/A

Report date: 2025/11/13 16:05:14
NME

Base Information

Drug NameHGP-3918
Drug Alias NameHGP3918HGP-3918
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin 17A inhibitors
TargetsInterleukin 17A
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHitgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesHitgen Inc
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A